Trump to visit Fed on Thursday amid Powell feud, renovation probe
LONDON - Investment giant BlackRock (NYSE:BLK), Inc. has increased its holdings in CVS Group PLC, crossing the 5% threshold that makes it a significant shareholder in the company. According to a standard form for notification of major holdings released on May 8, 2025, BlackRock now holds a combined total of 5.02% of the voting rights in CVS Group.
The notification, which follows the rules of the Disclosure Guidance and Transparency Rules Chapter 5, indicates that BlackRock’s acquisition of shares and financial instruments in CVS Group occurred on May 7, 2025. As a result of this transaction, BlackRock’s direct voting rights in CVS Group amount to 4.31%, with an additional 0.70% coming from financial instruments such as Contracts for Difference (CFDs) and securities lending.
The detailed breakdown provided in the notification shows that BlackRock directly holds 3,096,226 voting rights in CVS Group, which represents 4.31% of the company’s total voting rights. The financial instruments held by BlackRock, which include securities lending and CFDs, account for a further 137,885 and 370,536 voting rights, respectively.
Prior to this acquisition, BlackRock’s stake in CVS Group was below the 5% mark, which is the lowest threshold for mandatory disclosure according to UK financial regulations. The increase in BlackRock’s holdings has made it necessary for the company to notify both CVS Group and the Financial Conduct Authority of the change in its position.
The press release statement outlines a complex chain of ownership, with BlackRock’s stake in CVS Group being held through a series of controlled undertakings, including BlackRock Finance, Inc., BlackRock Holdco 2, Inc., and several other entities across different jurisdictions.
This information is based on a press release statement and serves to inform the market of changes in significant shareholdings in CVS Group PLC. As BlackRock surpasses the 5% mark, it becomes one of the major shareholders with a notable say in the company’s strategic decisions. The disclosure does not necessarily imply any further action by BlackRock, but it does provide transparency to the market regarding the distribution of voting rights in CVS Group.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.